The VISION Forward: Recognition and Implication of PSMA2/F-18-FDG1 mCRPC

Jadvar, H

Jadvar, H (通讯作者),Univ Southern Calif, Keck Sch Med, Dept Radiol, Div Nucl Med, Los Angeles, CA 90033 USA.

JOURNAL OF NUCLEAR MEDICINE, 2022; 63 (6): 812

Abstract

Metastatic castration resistant prostate cancer (mCRPC) is incurable. The expression of the transmembrane protein prostate-specific membrane antigen (......

Full Text Link